Format

Send to

Choose Destination
Am J Hematol. 2018 May;93(5):E123-E125. doi: 10.1002/ajh.25063. Epub 2018 Feb 24.

Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience.

Author information

1
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
2
Division of Hematology, Mayo Clinic, Rochester, Minnesota.
PMID:
29417621
DOI:
10.1002/ajh.25063
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center